ConductScience.org, home

Paper6791675

In vitro sensitivity of human ovarian tumours to chemotherapeutic agents.

Wilson AP and 1 other. Br J Cancer, 1981. Cited by 34 papers, by iCite.

Cite this record

ConductScience Library. In vitro sensitivity of human ovarian tumours to chemotherapeutic agents. Papers, record 6791675. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6791675

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In vitro sensitivity of human ovarian tumours to chemotherapeutic agents.
PubMed
Journal
Br J Cancer
PubMed
Year
1981
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
34
iCite
Relative citation ratio, by iCite
2.08
iCite
Revised in PubMed
2019-05-15
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wilson APA P
2Neal FEF E

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Ovarian NeoplasmsMajor topic
Alkylating Agents
Antimetabolites, Antineoplastic
Cell Survival
Cells, Cultured
Dactinomycin
Drug Evaluation, Preclinical
Drug Resistance
Drug Therapy, Combination
Female
Fluorouracil
Humans
Thiotepa

Source PubMed

Download CSV of topics

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11139861Pharmacokinetics of actinoymcin D in patients with malignant melanoma.Clin Pharmacol Ther1975https://conductscience.org/library/papers/1139861PubMed
24462060Assessment of an in vitro screening test of cytotoxic agents in the treatment of advanced malignant disease.Oncology1974https://conductscience.org/library/papers/4462060PubMed
31156513Assay of anti-cancer drugs in tissue culture: conditions affecting their ability to incorporate 3H-leucine after drug treatment.Br J Cancer1975https://conductscience.org/library/papers/1156513PubMed
4809049Fresh explant culture of human tumours in vitro and the assessment of sensitivity to cytotoxic chemotherapy.Br J Cancer1975https://conductscience.org/library/papers/809049PubMed
51175172Preliminary pharmacokinetic model for adriamycin (NSC-123127).Cancer Chemother Rep1975https://conductscience.org/library/papers/1175172PubMed
6850579Single agent vs combination chemotherapy in the treatment of ovarian cancer.Obstet Gynecol1977https://conductscience.org/library/papers/850579PubMed
7889590Pharmacokinetics and metabolism of vinblastine in humans.Cancer Res1977https://conductscience.org/library/papers/889590PubMed
8872088Pharmacokinetics of vindesine and vincristine in humans.Cancer Res1977https://conductscience.org/library/papers/872088PubMed
9890697Medroxyprogesterone acetate for the treatment of metastatic and recurrent ovarian carcinoma.Cancer Treat Rep1977https://conductscience.org/library/papers/890697PubMed
10597362Use of high dose corticosteroids in patients with inoperable brain tumours.J Neurol Neurosurg Psychiatry1977https://conductscience.org/library/papers/597362PubMed
11413551In vitro studies with hexamethylmelamine.Biochem Pharmacol1977https://conductscience.org/library/papers/413551PubMed
12348078Patterns of resistance and therapeutic synergism among alkylating agents.Antibiot Chemother (1971)1978https://conductscience.org/library/papers/348078PubMed
1395953In vivo studies with hexamethylmelamine.Eur J Cancer (1965)1978https://conductscience.org/library/papers/95953PubMed
14688279Plasma levels and urinary excretion of filterable platinum species following bolus injection and iv infusion of cis-dichlorodiammineplatinum(II) in man.Cancer Treat Rep1978https://conductscience.org/library/papers/688279PubMed
15698034A procedure for monitoring cyclophosphamide and isophosphamide in biological samples.Br J Clin Pharmacol1978https://conductscience.org/library/papers/698034PubMed
16498174Pharmacokinetics and metabolism of chlorambucil in man: a preliminary report.Cancer Treat Rev1979https://conductscience.org/library/papers/498174PubMed
1793985Bleomycin pharmacokinetics in man. II. Intracavitary administration.Cancer Chemother Pharmacol1979https://conductscience.org/library/papers/93985PubMed
186105478In-vitro clonogenic assay for predicting response of ovarian cancer to chemotherapy.Lancet1980https://conductscience.org/library/papers/6105478PubMed
205702360Chemotherapy in the treatment of advanced pelvic malignant disease with special reference to ovarian cancer.J Obstet Gynaecol Br Commonw1968https://conductscience.org/library/papers/5702360PubMed
214193360In-vitro screening test for human malignant tumours before chemotherapy.Lancet1970https://conductscience.org/library/papers/4193360PubMed

See all 27 referencesDownload CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.

PMIDTitleJournalYearIn PapersSource
6849794A short-term in vitro test for tumour sensitivity to adriamycin based on flow cytometric DNA analysis.Br J Cancer1983https://conductscience.org/library/papers/6849794PubMed
6540594Ovarian carcinoma cells in culture: assessment of drug sensitivity by clonogenic assay.Br J Cancer1984https://conductscience.org/library/papers/6540594PubMed
6409137Clinical correlates of in vitro drug sensitivities of ovarian cancer cells.Br J Cancer1983https://conductscience.org/library/papers/6409137PubMed
6381380The human tumor colony-forming chemosensitivity assay: a biological and clinical review.Invest New Drugs1984https://conductscience.org/library/papers/6381380PubMed
6197986A comparison of three assays used for the in vitro chemosensitivity testing of human tumours.Br J Cancer1984https://conductscience.org/library/papers/6197986PubMed
4063134DNA index of ovarian carcinomas from 56 patients: in vivo in vitro studies.Br J Cancer1985https://conductscience.org/library/papers/4063134PubMed
4040769Cystic fluid-platinum kinetics in ovarian cancer patients: relevance to cis-dichlorodiammine platinum (II) sensitivity testing in vitro.Br J Cancer1985https://conductscience.org/library/papers/4040769PubMed
3435704cis-platinum and ovarian carcinoma. In vitro chemosensitivity of cultured tumour cells from patients receiving high dose cis-platinum as first line treatment.Br J Cancer1987https://conductscience.org/library/papers/3435704PubMed
3219277The treatment of intraperitoneal malignant disease with monoclonal antibody guided 131I radiotherapy.Br J Cancer1988https://conductscience.org/library/papers/3219277PubMed
3139316Pharmacokinetics of thio-TEPA at two different doses.Cancer Chemother Pharmacol1988https://conductscience.org/library/papers/3139316PubMed
3105905Single and repeated dose pharmacokinetics of thio-TEPA in patients treated for ovarian carcinoma.Cancer Chemother Pharmacol1987https://conductscience.org/library/papers/3105905PubMed
2426218Activity of 2-fluoro-Ara AMP against gynecologic tumors in the soft agar assay.Invest New Drugs1986https://conductscience.org/library/papers/2426218PubMed
1451231Antitumor activity of treosulfan against human breast carcinomas.Cancer Chemother Pharmacol1992https://conductscience.org/library/papers/1451231PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6791675

GET https://conductscience.org/api/papers/v1/6791675/references?page=2